Indivior Inc. on Thursday won a bid to temporarily block New Jersey-based Alvogen Pine Brook Inc. from selling a generic version of the opioid addiction treatment drug Suboxone, which is at the center of an ongoing patent row, according to an order from a Garden State federal judge…

Read this piece in its entirety at Law360.